Senolytics work by selectively inducing apoptosis (programmed cell death) in senescent cells. They achieve this by targeting specific pathways that are upregulated in senescent cells. Common targets include the BCL-2 family of proteins, which regulate apoptosis, and the PI3K/AKT pathway, which is involved in cell survival.
